Hauck & Aufhaeuser set a €80.00 ($91.95) price objective on Gerresheimer AG (ETR:GXI) in a research report sent to investors on Friday morning. The brokerage currently has a neutral rating on the stock.
Other research analysts have also issued reports about the company. J P Morgan Chase & Co set a €99.80 ($114.71) target price on Gerresheimer AG and gave the company a buy rating in a research report on Wednesday, May 31st. Berenberg Bank set a €85.00 ($97.70) price objective on Gerresheimer AG and gave the company a buy rating in a report on Wednesday, May 24th. Deutsche Bank AG set a €82.00 ($94.25) price objective on Gerresheimer AG and gave the company a buy rating in a report on Friday, July 7th. Goldman Sachs Group, Inc. (The) set a €73.00 ($83.91) price objective on Gerresheimer AG and gave the company a neutral rating in a report on Friday, June 30th. Finally, Commerzbank Ag set a €73.00 ($83.91) price objective on Gerresheimer AG and gave the company a neutral rating in a report on Monday, June 26th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average target price of €80.06 ($92.02).
Shares of Gerresheimer AG (GXI) traded up 2.52% on Friday, reaching €71.69. The company’s stock had a trading volume of 250 shares. The stock has a market cap of €2.25 billion and a PE ratio of 19.09. Gerresheimer AG has a 12-month low of €64.00 and a 12-month high of €79.47. The firm has a 50 day moving average price of €74.42 and a 200-day moving average price of €73.18.
WARNING: This news story was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/2723979/gerresheimer-ag-etrgxi-given-a-80-00-price-target-at-hauck-aufhaeuser.html.
Gerresheimer AG Company Profile
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.